Health Care • Medical/Dental Instruments
$1.20 ▲ +0.06
(+5.26%)
MKT CAP: $5.7M • VOL: 20.7K
52W L $1 52W H $4
ROARABLE / RQD
D • 44/100
PIOTROSKI
4 / 9
SNOA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $19.5M | $14.3M | $12.7M |
| YoY Revenue Growth % | +36.7% | +12.2% | — |
| Gross Profit | $7.4M | $5.5M | — |
| Gross Margin % | 38.0% | 38.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.5M | -$3.7M | -$4.7M |
| Operating Margin % | -12.6% | -26.0% | -36.9% |
| Net Income (GAAP) | $3.2K | $3.5K | $4.8K |
| EBITDA (Normalized) | -$2.3M | -$3.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.9M | -$88.0K | -$2.4M |
| Capital Expenditures (CapEx) | $192.0K | $80.0K | — |
| Free Cash Flow (FCF) | -$4.1M | -$168.0K | -$2.4M |
| FCF Margin % | -21.1% | -1.2% | -18.8% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.6M | $5.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $3.4M | $4.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SNOA.